Delivery Order SPE2DB22D2206-SPE2DB25FJV08
- Not listed
- The Defense Logistics Agency awarded a $18,567.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of IMFINZI 500 mg/10 ml vials. The contract is a non-set-aside competitive award with a completion date of September 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $53,051.40 to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials. This competitively awarded, firm fixed-price contract is scheduled for completion by September 24, 2025, with performance occurring at AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of IMFINZI 500 mg/10 ml vials with a ceiling value of $53,051.40 and a firm fixed price contract type. The order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,305.14 for IMFINZI 500 mg/10 ml vials on August 25, 2025, with completion anticipated by September 16, 2025. This firm fixed price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,903.44 for IMFINZI (120 mg/2.4 mL vials), an oncology pharmaceutical product. This firm fixed-price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of September 16, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $6,344.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of IMFINZI (120 mg/2.4 mL vials). This is a non-set-aside contract with an ultimate completion date of September 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the vendor's corporate office location in Conshohocken,...
- This delivery order, awarded on July 31, 2025, to AmerisourceBergen Drug Corp represents a $1,903.44 firm fixed-price contract for IMFINZI 120 mg/2.4 ml vials to be delivered by August 21, 2025. The contract was funded by the Defense Logistics Agency (DLA), the Department of Defense's supply and logistics arm, with performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this award, indicating it was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,305.14 to AmerisourceBergen Drug Corp for Imfinzi 500 mg/10 mL vials on July 31, 2025. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of IMFINZI 500 MG/10 ML vials valued at $26,525.70 with a firm fixed price structure. This contract is non-set-aside and competitively awarded, with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 MG/10 ML VIAL 10ML pharmaceutical products. The $20,560.00 firm-fixed-price contract has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJV08Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $21,220.56 to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials. This firm fixed price delivery order, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and operates as the prime contractor on this delivery order. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs. IMFINZI, an oncology therapeutic, represents one of the specialized pharmaceutical products the contractor provides through this delivery order mechanism to support Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.2k | 9/8/25 |